UroGen Pharma Ltd Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 05/15/2026 | 4.54 M | $81.70 M | 0.00% | 9.23% |
| BLACKROCK, INC. | 05/13/2026 | 2.85 M | $51.16 M | 9.40% | 5.78% |
| TORONTO DOMINION BANK | 05/15/2026 | 2.62 M | $47.05 M | 100.00% | 5.32% |
| MORGAN STANLEY | 05/15/2026 | 2.56 M | $46.03 M | -0.11% | 5.20% |
| KYNAM CAPITAL MANAGEMENT, LP | 05/15/2026 | 2.25 M | $40.41 M | 100.00% | 4.57% |
| JEFFERIES FINANCIAL GROUP INC. | 05/08/2026 | 2.20 M | $39.55 M | 0.00% | 4.47% |
| PARADIGM BIOCAPITAL ADVISORS LP | 05/15/2026 | 1.70 M | $30.64 M | -61.91% | 3.46% |
| ACORN CAPITAL ADVISORS, LLC | 05/15/2026 | 1.67 M | $30.09 M | 15.53% | 3.40% |
| SG AMERICAS SECURITIES, LLC | 04/16/2026 | 1.66 M | $29.81 M | 20.34% | 3.37% |
| AMERICAN CENTURY COMPANIES INC | 05/15/2026 | 1.64 M | $29.44 M | 20.51% | 3.33% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 05/14/2026 | 1.50 M | $27.02 M | -13.56% | 3.05% |
| OPALEYE MANAGEMENT INC. | 05/15/2026 | 1.43 M | $25.71 M | 432.74% | 2.90% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 05/15/2026 | 1.31 M | $23.63 M | 68.13% | 2.67% |
| MENORA MIVTACHIM HOLDINGS LTD. | 05/14/2026 | 1.15 M | $20.72 M | 0.00% | 2.34% |
| D. E. SHAW & CO., INC. | 05/15/2026 | 1.02 M | $18.40 M | 6.29% | 2.08% |
| BIOIMPACT CAPITAL LLC | 05/15/2026 | 943.80 K | $16.97 M | 0.26% | 1.92% |
| J. GOLDMAN & CO LP | 05/15/2026 | 938.87 K | $16.88 M | 82.91% | 1.91% |
| ORBIMED ADVISORS LLC | 05/15/2026 | 875.49 K | $15.74 M | 0.00% | 1.78% |
| STATE STREET CORP | 05/15/2026 | 874.18 K | $15.72 M | 8.27% | 1.78% |
| MIGDAL INSURANCE & FINANCIAL HOLDINGS LTD. | 05/14/2026 | 770.91 K | $13.86 M | 0.00% | 1.57% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 05/14/2026 | 727.00 K | $13.07 M | 384.67% | 1.48% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 598.53 K | $10.76 M | 30.19% | 1.22% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 523.83 K | $9.42 M | 10.23% | 1.06% |
| WOODLINE PARTNERS LP | 05/15/2026 | 500.73 K | $9.00 M | 0.00% | 1.02% |
| BOXER CAPITAL MANAGEMENT, LLC | 05/15/2026 | 500.00 K | $8.99 M | 0.00% | 1.02% |
| 05/08/2026 | 409.56 K | $7.36 M | 100.00% | 0.83% | |
| TCG CROSSOVER MANAGEMENT, LLC | 05/15/2026 | 405.37 K | $7.29 M | -43.49% | 0.82% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 05/18/2026 | 395.46 K | $7.11 M | 215.42% | 0.80% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 05/14/2026 | 387.37 K | $6.96 M | -46.08% | 0.79% |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 05/14/2026 | 387.07 K | $6.96 M | -65.60% | 0.79% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 370.90 K | $6.67 M | -40.08% | 0.75% |
| TANG CAPITAL MANAGEMENT LLC | 05/15/2026 | 350.00 K | $6.29 M | 0.00% | 0.71% |
| RICE HALL JAMES & ASSOCIATES, LLC | 05/15/2026 | 285.83 K | $5.14 M | 1.40% | 0.58% |
| NORTHERN TRUST CORP | 05/14/2026 | 275.94 K | $4.96 M | 16.21% | 0.56% |
| PARKMAN HEALTHCARE PARTNERS LLC | 05/15/2026 | 275.00 K | $4.94 M | 62.95% | 0.56% |
| CITADEL ADVISORS LLC | 05/15/2026 | 268.00 K | $4.82 M | -63.67% | 0.54% |
| PRIVIUM FUND MANAGEMENT B.V. | 05/05/2026 | 238.12 K | $4.28 M | 10.95% | 0.48% |
| DEUTSCHE BANK AG\ | 05/06/2026 | 236.19 K | $4.25 M | -35.59% | 0.48% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 05/15/2026 | 230.63 K | $4.15 M | -47.04% | 0.47% |
| 05/15/2026 | 220.00 K | $3.96 M | 120.00% | 0.45% | |
| ALLY BRIDGE GROUP (NY) LLC | 05/18/2026 | 202.12 K | $3.63 M | 100.00% | 0.41% |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 05/13/2026 | 183.50 K | $3.30 M | 13.33% | 0.37% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 177.90 K | $3.20 M | -26.25% | 0.36% |
| UBS GROUP AG | 05/05/2026 | 159.66 K | $2.87 M | -32.07% | 0.32% |
| SCHONFELD STRATEGIC ADVISORS LLC | 05/15/2026 | 158.11 K | $2.84 M | 100.00% | 0.32% |
| ATOM INVESTORS LP | 05/15/2026 | 145.34 K | $2.61 M | -38.00% | 0.30% |
| FMR LLC | 05/15/2026 | 144.96 K | $2.61 M | 17.32% | 0.29% |
| AQR CAPITAL MANAGEMENT LLC | 05/15/2026 | 144.06 K | $2.59 M | -6.10% | 0.29% |
| VESTAL POINT CAPITAL, LP | 05/15/2026 | 139.08 K | $2.50 M | 100.00% | 0.28% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 126.78 K | $2.28 M | -1.44% | 0.26% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
UroGen Pharma Ltd institutional Ownership - FAQ's
During the previous two years, 214 institutional investors and hedge funds held shares of UroGen Pharma Ltd. The most heavily invested institutionals were:
RTW INVESTMENTS, LP: 4.54 M
BlackRock, Inc.: 2.85 M
TORONTO DOMINION BANK: 2.62 M
MORGAN STANLEY: 2.56 M
Kynam Capital Management, LP: 2.25 M
Jefferies Financial Group Inc.: 2.2 M
94.29% of UroGen Pharma Ltd stock is owned by institutional investors.
Institutional investors have bought a total of 53.76 M shares in the last 24 months. This purchase volume represents approximately $1.07 B in transactions.